European Atherosclerosis Society (EAS) & Congress

European Atherosclerosis Society (EAS) & Congress For more than 50 years the Society’s expertise has been used to teach clinicians how to manage lipid disorders and how to prevent atherosclerosis.

The European Atherosclerosis Society (EAS) was founded in 1964 with the aim of “advancing and exchanging knowledge concerning the causes, natural history, treatment and prevention of atherosclerotic disease”. By offering to our members access to educational materials, and opportunities to take part in Congress and courses, and by providing a forum in which new developments can be discussed, EAS contributes to the development of knowledge in the field, and ultimately to the improved treatment of persons with cardiovascular disease and lipid disorders. In recent years the Society has made a particular effort to recruit young scientists and clinicians also from other related disciplines. What we do
The European Atherosclerosis Society’s goal is to provide a framework for concerted scientific and clinical discussion of new developments in basic research, diagnosis and therapy of atherosclerosis. EAS is active in the publication of Guidelines and Consensus Position Papers, and its official Journal is Atherosclerosis. Through a regular series of Featured Commentaries EAS puts into perspective topical issues of relevance to our members. The Society organizes an annual Congress for approximately 2000 delegates, and runs a programme of Advanced Courses for both basic scientists and clinicians. EAS Academy is the Society's online e-Learning resource, containing a range of educational material and self-teaching programmes.

19/12/2025

With the holding great promise, Prof. Donna Fitzsimons shares her expectations for the impact to come.

In line with the Safe Hearts Plan ♥️, and building on the Commission’s vision for personalised prevention, EAS, Lp(a) an...
19/12/2025

In line with the Safe Hearts Plan ♥️, and building on the Commission’s vision for personalised prevention, EAS, Lp(a) and FHEF stand ready to support the development of an EU Protocol on Cardiovascular Health Checks that integrates early-life screening into a coherent lifecourse approach. Such a protocol should include systematic lipid screening for children in the first decade of life, integrated into existing child health and vaccination programmes; measurement of a full lipid profile including LDL cholesterol, Lp(a) and triglycerides; family-based cascade and reverse-cascade testing; and seamless integration with adult cardiometabolic health checks.

Digital tools and artificial intelligence, aligned with the European Health Data Space, should be used to support risk prediction and personalised prevention, while ensuring transparency, explainability and clinician-mediated decision-making, in line with patient trust and ethical standards.

This approach is fully aligned with findings from Commission co-funded projects, including PERFECTO FH and FH-EARLY, and supports the Plan’s objectives to reduce inequalities, improve outcomes and strengthen health system sustainability.

📄 Read the full statement: https://lnkd.in/ekJSf2SU

(ENG version below) Dada la elevada prevalencia de la enfermedad vascular aterosclerótica, los médicos se enfrentan con ...
18/12/2025

(ENG version below) Dada la elevada prevalencia de la enfermedad vascular aterosclerótica, los médicos se enfrentan con frecuencia a problemas relacionados con el tratamiento de sus diferentes aspectos. Este programa mejorará la atención clínica de los pacientes con enfermedades cardiovasculares o en prevención cardiovascular; además, los investigadores en ciencias clínicas, epidemiología e investigación cardiovascular traslacional obtendrán conocimientos valiosos que mejorarán la investigación en su campo.

El curso cuenta con el respaldo de la Sociedad Europea de Aterosclerosis (EAS) y representa el primer programa internacional de este tipo en español.

➡️ Iniciar el curso: https://eas.to/CELLLatAm

----------------------------------------------------------

Due to the high prevalence of atherosclerotic vascular disease, physicians frequently face challenges related to managing its various aspects. This program will help improve the clinical care of patients with cardiovascular disease or those under cardiovascular prevention. In addition, researchers in clinical sciences, epidemiology, and translational cardiovascular research will gain valuable knowledge that will help advance research in their field.

The course is supported by the European Atherosclerosis Society (EAS) and represents the first international program of its kind offered in Spanish.

➡️ Start the course: https://eas.to/CELLLatAm

Did you know?Ancient Greek athletes followed strict training and diet regimens long before sports science existed.Olympi...
18/12/2025

Did you know?

Ancient Greek athletes followed strict training and diet regimens long before sports science existed.

Olympic athletes in classical Greece practiced structured routines that closely resemble today’s exercise recommendations for cardiovascular health.

As we look ahead to in Athens, it’s inspiring to reflect on
how deeply the roots of health, discipline, and performance run in this city.
Discover more about the host city → https://eas-congress.com/2026

Have you enrolled in Your Lipid Clinic for Today: Wave 1? As an EAS member, you are eligible for a 50% discount as a new...
18/12/2025

Have you enrolled in Your Lipid Clinic for Today: Wave 1? As an EAS member, you are eligible for a 50% discount as a new benefit.

This case-based course for physicians in cardiovascular disease, endocrinology, and internal medicine brings dyslipidaemia management to life through real patient scenarios. As each case unfolds, you’ll interpret clinical data, refine diagnoses, and make treatment decisions - just as in everyday practice - before comparing your approach with expert, guideline-based recommendations.

Is there a better way to learn than from real clinical cases? Click here: https://eas.to/YLCWave1

17/12/2025

What will the deliver? Tune in to hear a short explanation.

The European Commission has officially published the - the first-ever comprehensive strategy to tackle the EU’s leadin...
17/12/2025

The European Commission has officially published the - the first-ever comprehensive strategy to tackle the EU’s leading cause of death and disability, which reflects years of advocacy and collaboration across the European Alliance for Cardiovascular Health.

Now, another step lies ahead. We must act to ensure smooth adoption at the national level addressing local conditions and lived experience.

Learn more:
🇪🇺 Communication from the Commission on an EU Cardiovascular Health Plan: The Safe Hearts Plan - https://health.ec.europa.eu/publications/communication-eu-cardiovascular-health-plan-safe-hearts-plan_en
🇪🇺 Factsheet: The EU Safe Hearts Plan - https://ec.europa.eu/commission/presscorner/detail/en/fs_25_3075
🇪🇺 Questions and answers on the EU Safe Hearts Plan - https://ec.europa.eu/commission/presscorner/detail/en/qanda_25_3080

The Plenary Programme for is now available.Each day of the congress will feature a dedicated plenary session exploring...
16/12/2025

The Plenary Programme for is now available.

Each day of the congress will feature a dedicated plenary session exploring key developments in atherosclerosis and related cardiovascular science.
From emerging therapeutic approaches to new insights in disease mechanisms, the plenaries set the stage for the discussions shaping this year’s meeting in Athens.

🔗 Explore the programme → https://bit.ly/3Kz5emA

We are delighted to announce that Prof. Heribert Schunkert has been awarded the 2026 Anitschkow Prize for his pioneering...
16/12/2025

We are delighted to announce that Prof. Heribert Schunkert has been awarded the 2026 Anitschkow Prize for his pioneering work in the genetics of atherosclerosis and cardiovascular disease.

We warmly congratulate and look forward to his Anitschkow Lecture, titled “The interplay of genetics and modifiable risk in atherosclerosis“, which will be presented during the EAS Congress Opening Ceremony on 24 May in Athens, Greece.

Read more about Professor Schunkert and his achievements here: https://eas.to/Anitschkow2026

15/12/2025

As the nears its release, Prof. Donna Fitzsimons reflects on how the alliance came together and evolved - placing patients at the centre, united by a single mission and a shared vision.

Being an EAS member is your privilege. Make the most of it. From 15 December to 29 January, all EAS individual members a...
15/12/2025

Being an EAS member is your privilege. Make the most of it. From 15 December to 29 January, all EAS individual members are invited to vote in the Election Committee (ELCOM) election.

Members may select 1-4 candidates. The candidates receiving the highest number of votes will be appointed to the committee. The four top-ranked nominees will become the new ELCOM members.

Read more and vote here: https://eas.to/ELCOMVot2025

As the holiday break approaches, take a moment to explore our Featured Open Lecture for November–December 2025. Prof. Ge...
14/12/2025

As the holiday break approaches, take a moment to explore our Featured Open Lecture for November–December 2025. Prof. Gemma Figtree examines acute coronary syndromes in patients without standard modifiable risk factors - an important group that makes up about 25% of heart attack cases. Notably, women without SMuRFs face the worst outcomes. Her lecture highlights why early plaque detection and deeper insight into susceptibility and resilience are essential for advancing prevention: https://eas.to/OpenNov25

Adress

Första Långgatan 4A
Gothenburg
41303

Webbplats

Aviseringar

Var den första att veta och låt oss skicka ett mail när European Atherosclerosis Society (EAS) & Congress postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Kontakta Praktiken

Skicka ett meddelande till European Atherosclerosis Society (EAS) & Congress:

Genvägar

Dela

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram